Nolan Sean P.

CIK 00015699266 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001569926

Recent Transactions

50 trades

Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2026-01-12+648,000→ 648,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12+1,008,000→ 3,086,358 total
Award
Ventas, Inc.$VTR
Common Stock
2025-05-13$64.18/sh+2,882→ 24,134 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-01-02+892,500→ 2,078,358 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-01-02+892,500→ 892,500 total
Award
Ventas, Inc.$VTR
Common Stock
2024-05-14$47.96/sh+3,648→ 21,252 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-01-02+1,184,688→ 1,185,858 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2024-01-02+1,184,688→ 1,184,688 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-12-14+466,550→ 466,550 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-16$0.90/sh+444,444→ 1,535,545 total
Award
Ventas, Inc.$VTR
Common Stock
2023-05-16$45.63/sh+3,835→ 17,604 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-12-30+1,106,131→ 1,106,131 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 total
Award
Ventas, Inc.$VTR
Common Stock
2022-04-27$57.25/sh+3,056→ 13,769 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2021-06-17+15,500→ 15,500 total
Award
Ventas, Inc.$VTR
Common Stock
2021-05-25+3,158→ 10,713 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-05-20$22.35/sh+1,170→ 1,170 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-28+1,089,500→ 1,089,500 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Series A Preferred Stock
2020-09-28−1,000,000→ 0 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-28+1,601→ 1,091,101 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Series B Preferred Stock
2020-09-28−1,470→ 0 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2020-09-23+31,000→ 31,000 total
Award
Ventas, Inc.$VTR
Common Stock
2020-05-18+5,424→ 7,555 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2020-05-05+25,000→ 25,000 total
Award
Neurogene Inc.$NGNE
Stock Option (right to buy)
2019-10-10+22,000→ 22,000 total
Award
Ventas, Inc.$VTR
Common Stock
2019-07-26$67.03/sh+2,131→ 2,131 total
Disposition to Issuer
AveXis, Inc.
Common Stock
2018-05-15−11,000→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−728,300→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−110,000→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−96,000→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−44,000→ 0 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2018-05-07+15,000→ 15,000 total
Award
AveXis, Inc.
Common Stock
2018-03-13+11,000→ 11,000 total
Award
AveXis, Inc.
Employee Stock Option (Right to Buy)
2018-03-13+44,000→ 44,000 total
Exercise/Conversion
AveXis, Inc.
Common Stock
2018-03-07$15.94/sh+10,000→ 10,000 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$126.65/sh−400→ 9,600 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$130.78/sh−600→ 1,100 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$131.86/sh−1,100→ 0 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$127.65/sh−700→ 8,900 total
Exercise/Conversion
AveXis, Inc.
Employee Stock Option (Right to Buy)
2018-03-07−10,000→ 728,300 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$128.65/sh−2,400→ 6,500 total
Sale
AveXis, Inc.
Common Stock
2018-03-07$129.66/sh−4,800→ 1,700 total
Award
AveXis, Inc.
Employee Stock Option (Right to Buy)
2017-05-10+96,000→ 96,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2017-05-08+9,000→ 9,000 total
Award
AveXis, Inc.
Employee Stock Option (Right to Buy)
2016-06-20+110,000→ 110,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2016-05-09+7,500→ 7,500 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2015-03-12+10,000→ 10,000 total
Disposition to Issuer
INTERMUNE INC
Stock options (right to buy)
2014-09-29−20,000→ 0 total
Disposition to Issuer
INTERMUNE INC
Stock options (right to buy)
2014-09-29−22,500→ 0 total
Disposition to Issuer
INTERMUNE INC
Common stock
2014-09-29$74.00/sh−56,400→ 0 total

Nolan Sean P.

Recent Transactions

Companies

Recent Filings

Address